01.10.2025 • NewsPeoplePharmaBiopharma

Symeres Appoints Gabriella Gentile as Chief Operating Officer

Symeres has appointed Gabriella Gentile as Chief Operating Officer to lead global operations and drive transatlantic growth, leveraging her extensive experience in the pharmaceutical and biotech sectors.

Gabriella Gentile, COO, Symeres
Gabriella Gentile, COO, Symeres
© Symeres

Symeres, a global Contract Research, Development, and Manufacturing Organization (CRDMO), has appointed Gabriella Gentile as Chief Operating Officer (COO). This strategic addition to the executive team supports Symeres' transatlantic growth ambitions, building upon its strong foundations in existing and novel modalities. 

Gabriella brings more than 25 years of international experience in the pharmaceutical, medical device, and services industries. She has held senior roles at Catalent, Roche, and Aptuit, where she led major transformation programs focused on operational performance, lean methodologies, and change management. 

In her new role, Gabriella will lead the transformation of global operations at Symeres, focusing on expanding capabilities across the pharmaceutical value chain from inception to investigational new drug (IND). She will apply her proven leadership to align business operations with measurable performance outcomes, reinforcing Symeres' commitment to quality and customer satisfaction. 

"I'm delighted to join Symeres at this exciting time in their growth", said Gabriella Gentile, "Symeres operates under a cultural philosophy of openness and transparency, and I look forward to being part of developing new next-generation therapies". She added, "I am ambitious in my expectations of how my global operational experience can positively impact Symeres' growth targets, and I'm committed to delivering outstanding customer experiences. Symeres' growth trajectory makes this an exciting time to join." 

Guillaume Jetten, Symeres CEO, added, "I'm delighted that Gabriella has accepted this position. Gabriella brings a set of highly relevant skills and experience from both her background in medicinal chemistry, but also her decades of large Pharma and biotech experience that will support the future growth plans of Symeres". 

Most recently, Gabriella served as global improvement director at Catalent, where she developed and implemented standardized operational frameworks across multiple sites. Prior to that, she consulted independently on global change and operational excellence programs, helping organizations improve performance and implement strategic business initiatives. Her appointment marks another significant step in Symeres' expansion strategy, as the company positions itself as a global biotechnology leader, bridging European innovation and American market presence.

Company

Logo:

Symeres

Kerkenbos 1013
6546 BB Nijmegen
Netherlands

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.